Company Filing History:
Years Active: 1978-1981
Title: Matyas Szentivanyi: Innovator in Pharmaceutical Chemistry
Introduction
Matyas Szentivanyi is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds for medical applications. With a total of four patents to his name, Szentivanyi's work has the potential to impact the treatment of various health conditions.
Latest Patents
Szentivanyi's latest patents include innovative compounds such as O-(3-Amino-2-hydroxy-propyl)-amidoxime derivatives, which are effective in the treatment of diabetic angiopathy. He has also developed a selective .beta.-receptor blocker with a specific formula, where R.sup.2 can be a hydrogen or an alkyl group containing one to five carbon atoms. Additionally, he has worked on novel 17-aza-PGF.sub.2.alpha. derivatives and pharmaceutical N-Acylated 17-Aza-PGF.sub.2.alpha. compounds.
Career Highlights
Matyas Szentivanyi is associated with Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt., a company known for its pharmaceutical products. His work at this institution has allowed him to focus on innovative research and development in the pharmaceutical sector.
Collaborations
Szentivanyi has collaborated with notable colleagues such as Sandor Virag and Kalman Takacs. Their combined expertise has contributed to the advancement of their research projects and the successful development of new pharmaceutical compounds.
Conclusion
Matyas Szentivanyi is a distinguished inventor whose work in pharmaceutical chemistry continues to pave the way for new treatments. His innovative patents and collaborations highlight his commitment to improving healthcare through scientific advancements.